Alan Townsend
4Patents
3h-index
8Co-inventors
39Inventor score
Filing activity: Mar 24, 1994 → Mar 23, 2000
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5585461A | Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof | Emerging Cross-Sectional Technologies | 23 | Expired |
| US5591430A | Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof | Emerging Cross-Sectional Technologies | 18 | Expired |
| US5851523A | Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof | Human Necessities | 8 | Expired |
| US6682731B1 | Isolated peptides derived from mage tumor rejection antigen precursors which complex with HLA-A2 molecules | Human Necessities | 2 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.